Article
Ajay Singla, MD, has joined The University of Toledo Medical Center, Toledo, OH, and separately, David M. Barrett, MD, has been elected to the board of directors of ProUroCare Medical Inc. in Minneapolis.
FDA Advisory Committee unanimously votes against talazoparib plus enzalutamide for mCRPC
Pearls & Perspectives: From Guidelines to Practice—Navigating the TRT Treatment Spectrum, with Alex Tatem, MD
Pivotal trial launches of 64Cu-SAR-bisPSMA in BCR of prostate cancer
Pearls & Perspectives: Expanding BPH care & patient choice, with Kevin Zorn, MD, at AUA 25
Experts share insights on next-generation NMIBC therapies
Study shows value of precision-based approaches in prostate cancer
FDA Advisory Committee finds evidence for UGN-102 inconclusive, cites uncertainty in benefit-risk
Meeting with FDA paves way for phase 3 trial of PT-112 in mCRPC